Bone Growth Stimulator Market by Product, (Bone Growth Stimulation Devices, Bone Morphogenetic Proteins, and Platelet Rich Plasma), by Application, (Spinal Fusion Surgeries, Delayed Union & Non-Union Fractures, Oral and Maxillofacial Surgeries, and Others), and By End User (Hospitals & Clinics, Academic and Research Institutes, Contract Research Organizations, and Home Care) – Global Opportunity Analysis and Industry Forecast To 2022
Bone growth stimulator is a supplemental form of therapy worked on the potential generated by bones to enhance the body’s natural healing process. This can be used as an alternative to bone surgeries to provide easy access and minimal complications during surgeries with reduction of patient non-compliance. Global bone growth stimulator market is expected to reach USD 1,397.6 million by 2022, at a CAGR of 5.8% during the forecast period of 2017 to 2022.
Succeeding an extensive secondary and primary research on bone growth stimulator and an in-depth analysis of the market scenario, the report carries out an impact analysis of the key industry drivers, restraints, opportunities, and trends listed in the market dynamics segment. Growing geriatric population with the prevalence of orthopaedic issues and rising preference for stimulation treatments are the key market drivers covered in the report which will support the industry growth during the forecast period. However, complications associated with the use of bone morphogenetic proteins (BMP) and unfavorable reimbursement scenario related to bone growth stimulators hinders the growth of the market to some extent.
The global bone growth stimulator market report offers an extensive outlook on the various segments of the market. This market studied in the report is majorly segmented by product (bone growth stimulation devices, bone morphogenetic proteins, and platelet rich plasma), application (spinal fusion surgeries, delayed union & non-union fractures, oral and maxillofacial surgeries, and others), end user (hospitals & clinics, academic and research institutes, contract research organizations, and home care), and geography (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa).
The report further provides an extensive detail on the each segment and sub-segment covered in the report. For instance, the report briefly talks about the dynamics of the various applications of bone growth stimulators including spinal fusion surgeries, delayed union & non-union fractures, oral and maxillofacial surgeries, and others. Each application segment further briefly talks about the trends impacting the growth of these markets and the benefits involved with the use bone growth stimulators in these surgeries to improve overall treatment.
In addition, the report further gives an extensive outlook on various healthcare facilities served by the bone growth stimulator. These healthcare settings include hospitals & clinics, academic & research institutes, contract research organizations, and home care. These end user segments further briefly talks about the trends impacting the growth of these markets and the benefits involved with the use bone growth stimulator in these verticals to improve overall efficiency and outcomes of the orthopaedic surgeries for less painful and invasive treatment.
An in-depth analysis of the geographical scenario of the industry provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) along with the coverage of major countries in each region. The geographical analysis provides detailed insights on the key trends of the industry in the listed regions & countries, identifying the demographic & economic impact, government & private investments, and regulatory scenario. The report identifies North America to be the largest market followed by Europe, Asia Pacific, and Rest of World. The geographical analysis section also comments on the key market players shaping the growth of the industry in the respective countries.
The report also includes the competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 3 years (2014-2017).
The key players in the global bone growth stimulator market are Orthofix International N.V. (U.S.), DJO Global, Inc. (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Medtronic, plc (Ireland), Johnson & Johnson (U.S.), Stryker Corporation (U.S.), Bioventus Inc. (U.S.), Arthrex, Inc. (U.S.), ISTO Biologics (U.S.), Ossatec Benelux Ltd. (Netherland), Regen Lab SA (Switzerland), ITO CO., Ltd. (Japan), Altis Biologics (Pty) Ltd (South Africa), and Harvest Technologies Corporation (U.S.).
Scope of the report
Market by Product
Bone Growth Stimulation Devices
External Bone Growth Stimulator
Pulsed Electromagnetic Field Devices
Capacitive Coupling Devices
Combined Magnetic Field Devices
Implanted Bone Growth Stimulators
Ultrasonic Bone Growth Stimulators
Bone Morphogenetic Proteins
Platelet Rich Plasma
Market by Application
Spinal Fusion Surgeries
Delayed Union & Non-union Bone Fractures
Oral and Maxillofacial Bone surgeries
Market by End User
Hospitals & Clinics
Academic and Research Institutes
Contract Research Organizations
Market by Geography
Rest of Europe (RoE)
Rest of APAC (RoAPAC)
Middle East & Africa